FDA Drugs recall ·
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy recall
- Recall number
- D-0608-2025
- Date
- (initiated July 9, 2025)
- Company / brand
- Boothwyn Pharmacy LLC
221 Gale Ln, Kennett Square, PA, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 186 vials
- Hazard tags
- Potency
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Why was it recalled?
Subpotent Drug
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
03202025@9 BUD 07/18/2025
Distribution
U.S. Nationwide
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0608-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.